Save your place

Sign in to WhoBought

Please try again later.

Sana Biotechnology, Inc. (SANA) institutional ownership

Latest close $3.28 Jul 27, 2026
Market cap$790M 52-week range SectorHealthcare
Funds holding · Q1 2026
172
reported SANA position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
90 buyers · 82 sellers

Sana Biotechnology, Inc. (SANA) price and institutional activity

Dates

Q1 2026

$0 bought by 90 investors
State StreetBank of America Corp +88 more
$0 sold by 82 investors
Great Point Partners LLCBalyasny Asset Management L.P. +80 more
Bought Sold Totals per quarter; hover a bar for the names.

Sana Biotechnology, Inc. (SANA) institutional activity · 172

Investor Type Est. change Change Δ Own Date
State Street · Added
Change +2.5M Date Q1 2026
State Street Added· Q1 2026 +2.5M Q1 2026
Bank of America Corp · Added
Change +1.8M Date Q1 2026
Bank of America Corp Added· Q1 2026 +1.8M Q1 2026
Goldman Sachs Group Inc · Added
Change +1.7M Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +1.7M Q1 2026
Millennium Management LLC · Added
Change +968K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +968K Q1 2026
Great Point Partners LLC · Exited
Change −700K Δ Own −100.0% Date Q1 2026
Great Point Partners LLC Exited· Q1 2026 −700K −100.0% Q1 2026
Balyasny Asset Management L.P. · Reduced
Change −645K Date Q1 2026
Balyasny Asset Management L.P. Reduced· Q1 2026 −645K Q1 2026
Marshall Wace, LLP · Added
Change +576K Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +576K Q1 2026
T. Rowe Price Associates · Reduced
Change −559K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −559K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +556K +4102.7% Q1 2026
Jane Street Group, LLC · Reduced
Change −536K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −536K Q1 2026
Barclays PLC · Reduced
Change −478K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −478K Q1 2026
Crestline Management, L.P. · Reduced
Change −465K Date Q1 2026
Crestline Management, L.P. Reduced· Q1 2026 −465K Q1 2026
Two Sigma Investments, LP · Reduced
Change −381K Δ Own −24.1% Date Q1 2026
Two Sigma Investments, LP Reduced· Q1 2026 −381K −24.1% Q1 2026
Clearstead Advisors, LLC · Added
Change +332K Date Q1 2026
Clearstead Advisors, LLC Added· Q1 2026 +332K Q1 2026
Private Advisor Group, LLC · Exited
Change −309K Δ Own −100.0% Date Q1 2026
Private Advisor Group, LLC Exited· Q1 2026 −309K −100.0% Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 172

Famous investor activity in Sana Biotechnology, Inc. (SANA)

Sana Biotechnology, Inc. (SANA) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Bishop Hans Edgar · Director Grant (A) 6K
Owned 5.9M ΔOwn +0.1% Trade date Jul 6, 2026 Filed date Jul 7, 2026
Bishop Hans Edgar Director Grant (A) 6K 5.9M +0.1% Jul 6, 2026 Jul 7, 2026
Yang Patrick Y. · Director Grant (A) 90K
Owned 90K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Yang Patrick Y. Director Grant (A) 90K 90K Jun 4, 2026 Jun 5, 2026
Rosiello Robert L. · Director Grant (A) 90K
Owned 90K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Rosiello Robert L. Director Grant (A) 90K 90K Jun 4, 2026 Jun 5, 2026
Seitz Michelle · Director Grant (A) 90K
Owned 90K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Seitz Michelle Director Grant (A) 90K 90K Jun 4, 2026 Jun 5, 2026
Reicin Alise · Director Grant (A) 90K
Owned 90K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Reicin Alise Director Grant (A) 90K 90K Jun 4, 2026 Jun 5, 2026
Mulligan Richard · Director Grant (A) 90K
Owned 90K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Mulligan Richard Director Grant (A) 90K 90K Jun 4, 2026 Jun 5, 2026
Bishop Hans Edgar · Director Grant (A) 90K
Owned 90K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Bishop Hans Edgar Director Grant (A) 90K 90K Jun 4, 2026 Jun 5, 2026
Bilenker Joshua H. · Director Grant (A) 90K
Owned 90K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Bilenker Joshua H. Director Grant (A) 90K 90K Jun 4, 2026 Jun 5, 2026
Nelsen Robert · Director Grant (A) 90K
Owned 90K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Nelsen Robert Director Grant (A) 90K 90K Jun 4, 2026 Jun 5, 2026
Bishop Hans Edgar · Director Grant (A) 8K
Owned 5.8M Trade date Apr 6, 2026 Filed date Apr 8, 2026
Bishop Hans Edgar Director Grant (A) 8K 5.8M Apr 6, 2026 Apr 8, 2026
Harr Steve · Director, Officer 2 operations -$76K
Price $3.10–$3.13 Qty -24K Owned 7.9M Trade date Mar 9, 2026 Filed date Mar 10, 2026
Harr Steve Director, Officer 2 operations $3.10–$3.13 -24K -$76K 7.9M Mar 9, 2026 Mar 10, 2026
Wyrick Susan D. · Officer 2 operations -$14K
Price $3.10–$3.13 Qty -4K Owned 197K Trade date Mar 9, 2026 Filed date Mar 10, 2026
Wyrick Susan D. Officer 2 operations $3.10–$3.13 -4K -$14K 197K Mar 9, 2026 Mar 10, 2026
Harr Steve · Director, Officer 2 operations 0
Owned 100K Trade date Mar 7, 2026 Filed date Mar 10, 2026
Harr Steve Director, Officer 2 operations 0 100K Mar 7, 2026 Mar 10, 2026
Wyrick Susan D. · Officer 2 operations 0
Owned 6K Trade date Mar 7, 2026 Filed date Mar 10, 2026
Wyrick Susan D. Officer 2 operations 0 6K Mar 7, 2026 Mar 10, 2026
Harr Steve · Director, Officer 2 operations 0
Owned 125K Trade date Mar 6, 2026 Filed date Mar 10, 2026
Harr Steve Director, Officer 2 operations 0 125K Mar 6, 2026 Mar 10, 2026
15 of 21
15 of 21 Sign in to continue to older insider transactions.

Sana Biotechnology, Inc. (SANA) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Arch Venture Fund Ix, L.P. 44.0M
% of shares outstanding 22.3% Filing date Feb 9, 2024
Arch Venture Fund Ix, L.P. 44.0M 22.3% Feb 9, 2024
FMR LLC 22.2M
% of shares outstanding 10.1% Filing date Apr 3, 2024
FMR LLC 22.2M 10.1% Apr 3, 2024
Ra Capital Management, L.P. 18.8M
% of shares outstanding 6.3% Filing date May 21, 2026
Ra Capital Management, L.P. 18.8M 6.3% May 21, 2026
Vanguard Group Inc 13.2M
% of shares outstanding 5.9% Filing date Nov 4, 2024
Vanguard Group Inc 13.2M 5.9% Nov 4, 2024
Canada Pension Plan Investment Board 10.2M
% of shares outstanding 5.4% Filing date Feb 14, 2022
Canada Pension Plan Investment Board 10.2M 5.4% Feb 14, 2022
Blackrock, Inc. 11.8M
% of shares outstanding 5.3% Filing date Nov 8, 2024
Blackrock, Inc. 11.8M 5.3% Nov 8, 2024
Baillie Gifford & Co 10.4M
% of shares outstanding 4.7% Filing date Mar 7, 2024
Baillie Gifford & Co 10.4M 4.7% Mar 7, 2024
Flagship Ventures Fund V, L.P. 1.0M
% of shares outstanding 0.5% Filing date Feb 14, 2024
Flagship Ventures Fund V, L.P. 1.0M 0.5% Feb 14, 2024
8 of 8

Sana Biotechnology, Inc. (SANA) ownership FAQ

Who owns SANA?

172 reporting institutions disclosed SANA position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.